JNJ
JNJ
NEW YORK STOCK EXCHANGE, INC. · Pharmaceuticals

Johnson & Johnson

$221.32
-1.19 (-0.53%)
As of May 9, 2:01 AM ET ·
Analyst Consensus
Buy
32
Analysts
Very High
Coverage
Buy 20 63%
Hold 12 38%
Sell 0 0%
Price Target
Analyst Price Target +35.3% upside
Low Target $223.02
Average Target $299.55
High Target $400.15
Current Price $221.32
Current
$221.32
Target
$299.55
$223.02 $299.55 avg $400.15
Scenario Analysis
Bear Case
$223.02
0.8%
Low target
Base Case
$299.55
+35.3%
Avg target
Bull Case
$400.15
+80.8%
High target
Risk/Reward
105.2x
Highly favorable
Price in Context
52-Week High
$251.71
-12.1% from high
52-Week Low
$146.12
+51.5% from low
50-Day SMA
$219.25
+0.9% vs SMA
200-Day SMA
$185.17
+19.5% vs SMA
RSI (14)
88.6
Overbought
Target vs 52W High
$299.55
+19.0% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 69% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 35 43% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%